ELV - Elevance Health, Inc.

ELV

$428.09 +0.00 (+0.00%)

Pre-Market: $428.09 +0.00 (+0.00%)

Last updated: Oct 15, 2026 11:45

52-Week Range

$428.09

$274.84 $428.09 $436.24

Fundamentals Overview

Elevance Health, Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 18.8 PEG 4.23 P/B 1.87 P/S 0.46

Profitability

ROE 11.24% Net margin 2.5%

Risk (Beta)

0.65 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 55% confidence Risk: Lower Volatility — Beta 0.65. Diversify and only invest what you can afford to lose.

Supporting (Buy):

P/S 0.46 (value)

Pressures (Sell):

PEG 4.23

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$92.84B

P/E (TTM)

18.8

EPS (TTM)

N/A

Dividend Yield

1.24%

52-Week Range

$274.84 - $436.24

Volume vs Avg

N/A

Beta

0.65

About

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 ...

Sector: Healthcare

Headquarters: US

Website: www.elevancehealth.com

Beta: 0.65 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	18.8
PEG (TTM)	4.23
P/B (TTM)	1.87
P/S (TTM)	0.46
Profitability
ROE (TTM)	11.24%
ROA (TTM)	4%
Revenue growth (YoY)	N/A
Net margin (TTM)	2.47%
Operating margin (TTM)	3.63%
Debt to equity (TTM)	0.69

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ELV.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.